Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Immunopharmacology|October 11, 2020
Continuous tracking of COVID-19 patients' immune statusJingjing Guan, Xin Wei, Shuang Qin, et al.
Clinical Immunology (Orlando, Fla.)|June 24, 2020
COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potentialYujie Jiang, Xin Wei, Jingjing Guan, et al.
Scandinavian Journal of Immunology|May 10, 2019
Hyperactivated peripheral invariant natural killer T cells correlate with the progression of HBV-relative liver cirrhosisXin Wei, Jingjing Qian, Weifeng Yao, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2018
SUMO protease SENP1 deSUMOylates and stabilizes c-MycXiao-Xin Sun, Yingxiao Chen, Yulong Su, et al.
Immunology Letters|January 30, 2021
Highly activated TRAIL+ CD56bright NK cells are associated with the liver damage in HBV-LC patientsYujie Jiang, Shuang Qin, Xin Wei, et al.
Nucleic Acids Research|March 13, 2023
The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processingYingxiao Chen, Yanping Li, Roselyn S Dai, et al.
EMBO Reports|April 14, 2021
The deubiquitinase USP36 promotes snoRNP group SUMOylation and is essential for ribosome biogenesisHyunju Ryu, Xiao-Xin Sun, Yingxiao Chen, et al.
Nature Communications|January 10, 2019
Publisher Correction: Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapyHao Geng, Changhui Xue, Janet Mendonca, et al.
Nature Communications|November 28, 2018
Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapyHao Geng, Changhui Xue, Janet Mendonca, et al.
Pageof 2